Lamberto is an outstanding leader, with an impressive track record at Bristol-Myers Squibb of growing key franchises and businesses around the world.

A much better alternative to other alternatives that could have been considered.

For revenue and earnings growth to occur, we must stay focused on investing behind our pipeline and we must drive our current productivity efforts even harder in order to have the resources to fund those investments.

I've put together a proposal, based on negotiations with Metro-North, that I'll present at our next Town Board meeting for raising our fees and bringing them in line.

This new plan is intended to challenge the company over the next five years to again double sales, earnings and earnings per share, to create 'mega-blockbuster' products of several billion dollars and to pursue 'mega-blockbuster ideas' that can also add billions of dollars in revenue growth.

This agreement builds on Bristol-Myers Squibb's long-standing commitment to the global fight against AIDS.

We see a promising pipeline taking shape - one of the most promising pipelines in our company's history.

You could see in the beginning some modest positive benefit, but I think in a three-to-five-year time frame ... what we modeled into our business is (a) neutral to slightly negative impact.